4 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 26275572 | A window-of-opportunity biomarker study of etodolac in resectable breast cancer. | 2015 Oct | 3 |
| 2 | 21431842 | Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers. | 2011 Dec | 1 |
| 3 | 15802527 | SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma. | 2005 Jul 15 | 1 |
| 4 | 15193259 | Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgamma. | 2004 Jun | 1 |